Dian Diagnostics Group Co.,Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 24 June 2021
June 21, 2021 at 03:37 pm EDT
Share
Dian Diagnostics Group Co.,Ltd. announced 2020 final profit distribution plan to be implemented (A shares) of CNY 1.30000000 per 10 shares (tax included), with Record date: 23 June 2021; Ex-date: 24 June 2021; and Payment date: 24 June 2021.
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.